|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis显示文摘 | Federica Zoratto Luigi Rossi Monica Verrico Anselmo Papa Enrico Basso Angelo Zullo Luigi Tomao Adriana Romiti Giuseppe Lo Russo Silverio Tomao | 2014 | Tumor Biology2014，，7： | 3 |
| 2 | A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma显示文摘 | Raffaella Romeo Ersilio Del Ninno Mariagrazia Rumi Antonio Russo Angelo Sangiovanni Roberto de Franchis Guido Ronchi Massimo Colombo | 2009 | Gastroenterology2009，，5： | 2 |
| 3 | Evaluation of Tempol Radioprotection in a Murine Tumor Model显示文摘 | Stephen M Hahn Francis J Sullivan Anne Marie DeLuca C.Murali Krishna Nancy Wersto David Venzon Angelo Russo James B Mitchell | 1996 | Free Radical Biology and Medicine1996，，7： | 1 |
| 4 | Boceprevir or telaprevir in hepatitis C virus chronic infection:The Italian real life experience显示文摘AIM: To check the safety and efficacy of boceprevir/telaprevir with peginterferon/ribavirin for hepatitis C virus(HCV) genotype 1 in the real-world settings. METHODS: This study was a non-randomized, observational, prospective, multicenter. This study involved 47 centers in Italy. A database was prepared for the homogenous collection of the data, was used by all of the centers for data collection, and was updated continuously. All of the patients enrolled in this study were older than 18 years of age and were diagnosed with chronic infection due to HCV genotype 1. The HCV RNA testing was performed using COBAS-Taq Man2.0(Roche, LLQ 25 IU/m L). RESULTS: All consecutively treated patients were included. Forty-seven centers enrolled 834 patients as follows: Male 64%; median age 57(range 18-78), of whom 18.3% were over 65; mean body mass index 25.6(range 16-39); genotype 1b(79.4%); diagnosis of cirrhosis(38.2%); and fibrosis F3/4(71.2%). The following drugs were used: Telaprevir(66.2%) and PEG-IFN-alpha2a(67.6%). Patients were na?ve(24.4%), relapsers(30.5%), partial responders(14.8%) and null responders(30.3%). Overall, adverse events(AEs) occurred in 617 patients(73.9%) during the treatment. Anemia was the most frequent AE(52.9% of cases), especially in cirrhotic. The therapy was stopped for 14.6% of the patients because of adverse events or virological failure(15%). Sustained virological response was achieved in 62.7% of the cases, but was 43.8% in cirrhotic patients over 65 years of age. CONCLUSION: In everyday practice, triple therapy is safe but has moderate efficacy, especially for patients over 65 years of age, with advanced fibrosis, nonresponders to peginterferon + ribavirin. | Antonio Ascione Luigi Elio Adinolfi Pietro Amoroso Angelo Andriulli Orlando Armignacco Tiziana Ascione Sergio Babudieri Giorgio Barbarini Michele Brogna Francesco Cesario Vincenzo Citro Ernesto Claar Raffaele Cozzolongo Giuseppe D’Adamo Emilio D’Amico Pellegrino Dattolo Massimo De Luca Vincenzo De Maria Massimo De Siena Giuseppe De Vita Antonio Di Giacomo Rosanna De Marco Giorgio De Stefano Giulio De Stefano Sebastiano Di Salvo Raffaele Di Sarno Nunzia Farella Laura Felicioni Basilio Fimiani Luca Fontanella Giuseppe Foti Caterina Furlan Francesca Giancotti Giancarlo Giolitto Tiziana Gravina Barbara Guerrera Roberto Gulminetti Angelo Iacobellis Michele Imparato Angelo Iodice Vincenzo Iovinella Antonio Izzi Alfonso Liberti Pietro Leo Gennaro Lettieri Ileana Luppino Aldo Marrone Ettore Mazzoni Vincenzo Messina Roberto Monarca Vincenzo Narciso Lorenzo Nosotti Adriano Maria Pellicelli Alessandro Perrella Guido Piai Antonio Picardi Paola Pierri Grazia Pietromatera Francesco Resta Luca Rinaldi Mario Romano Angelo Rossini Maurizio Russello Grazia Russo Rodolfo Sacco Vincenzo Sangiovanni Antonio Schiano Antonio Sciambra Gaetano Scifo Filomena Simeone Annarita Sullo Pierluigi Tarquini Paolo Tundo Alfredo Vallone | 2016 | World Journal of Hepatology2016，8，22： | 1 |
| 5 | Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives显示文摘Motor neuron disease includes a heterogeneous group of relentless progressive neurological disorders defined and characterized by the degeneration of motor neurons.Amyotrophic lateral sclerosis is the most common and aggressive form of motor neuron disease with no effective treatment so far.Unfortunately,diagnostic and prognostic biomarkers are lacking in clinical practice.Neurofilaments are fundamental structural components of the axons and neurofilament light chain and phosphorylated neurofilament heavy chain can be measured in both cerebrospinal fluid and serum.Neurofilament light chain and phosphorylated neurofilament heavy chain levels are elevated in amyotrophic lateral sclerosis,reflecting the extensive damage of motor neurons and axons.Hence,neurofilaments are now increasingly recognized as the most promising candidate biomarker in amyotrophic lateral sclerosis.The potential usefulness of neurofilaments regards various aspects,including diagnosis,prognosis,patient stratification in clinical trials and evaluation of treatment response.In this review paper,we review the body of literature about neurofilaments measurement in amyotrophic lateral sclerosis.We also discuss the open issues concerning the use of neurofilaments clinical practice,as no overall guideline exists to date;finally,we address the most recent evidence and future perspectives. | Yuri Matteo Falzone Tommaso Russo Teuta Domi Laura Pozzi Angelo Quattrini Massimo Filippi Nilo Riva | 2021 | Neural Regeneration Research2021，16，10： | 1 |
| 6 | Smith photodynamic therapy显示文摘 | MICHEAL J MANYAK ANGELO RUSSO | 1988 | J Clin Oncolo1988，2，： | 1 |
| 7 | Do stable nitroxide radicals catalyze or inhibit the degradation of hyaluronic acid显示文摘 | Lurie Ziva Offer Tal Russo Angelo | 2003 | Free Radical Biology & Medicine2003，35，2： | 1 |
| 8 | A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma显示文摘 | Raffaella Romeo Ersilio Del Ninno Mariagrazia Rumi Antonio Russo Angelo Sangiovanni Roberto de Franchis Guido Ronchi Massimo Colombo | 2009 | Gastroenterology2009，，5： | 1 |
| 9 | Preoperative Characteristics and Postoperative Behavior of Bowel Wall on Risk of Recurrence After Conservative Surgery in Crohn’s Disease: A Prospective Study显示文摘 | Giovanni Maconi Gianluca M. Sampietro Massimo Cristaldi PierGiorgio Danelli Antonio Russo Gabriele Bianchi Porro Angelo Maria Taschieri | 2001 | Annals of Surgery2001，，3： | 1 |
| 10 | Histological substrate of human atrial fibrillation显示文摘 | Cristina Chimenti Matteo A. Russo Angelo Carpi Andrea Frustaci | 2009 | Biomedicine & Pharmacotherapy2009，，3： | 1 |
| 11 | Dilation assisted stone extraction for complex biliary lithiasis:Technical aspects and practical principles显示文摘Common bile duct stones are frequently diagnosed worldwide and are one of the main indications for endoscopic retrograde cholangio-pancreatography.Endoscopic sphincterotomy(EST)has been used for the removal of bile duct stones for the past 40 years,providing a wide opening to allow extraction.Up to 15%of patients present with complicated choledocholithiasis.In this context,additional therapeutic approaches have been proposed such as endoscopic mechanical lithotripsy,intraductal or extracorporeal lithotripsy,or endoscopic papillary large balloon dilation(EPLBD).EPLBD combined with EST was introduced in 2003 to facilitate the passage of large or multiple bile duct stones using a balloon greater than 12 mm in diameter.EPLBD without EST was introduced as a simplified technique in 2009.Dilation-assisted stone extraction(DASE)is the combination of two techniques:EPLBD and sub-maximal EST.Several studies have reported this technique as safe and effective in patients with large bile duct stones,without any increased risk of adverse events such as pancreatitis,bleeding,or perforation.Nevertheless,it is difficult to analyze the outcomes of DASE because there are no standard techniques and definitions between studies.The purpose of this paper is to provide technical guidance and specific information about the main issues regarding DASE,based on current literature and daily clinical experience in biliary referral centers. | Giuseppe Grande Silvia Cocca Helga Bertani Angelo Caruso Flavia Pigo' Santi Mangiafico Salvatore Russo Marinella Lupo Graziella Masciangelo Paolo Cantu' Raffaele Manta Rita Conigliaro | 2021 | World Journal of Gastrointestinal Endoscopy2021，13，2： | 0 |
| 12 | Latest results from GRAAL collaboration显示文摘The GRAAL experimental set-up consists of a polarized and tagged photon beam that covers an energy range from a minimum of 600 MeV up to a maximum of 1500 MeV, of a liquid Hydrogen or Deuterium target and of the 4π Lagrange detector optimized for photon detection. It allows the study of pseudo-scalar and vector meson photoproduction on the nucleon in the energy range corresponding to the second and the third resonance regions. In the following, the Σ beam asymmetries in η and π0 photoproduction on quasi-free nucleon are shown. Also single and double polarization observables in K+Λ photoproduction on free proton are shown; they are important to confirm the role of new or poorly known resonances in the 1900 MeV mass region. | V. Vegna V. Bellini J.P. Bouquet L. Casano A. D'Angelo J.P. Didelez R. Di Salvo A. Fantini D. Franco G. Gervino F. Ghio G. Giardina B. Girolami A. Giusa M. Guidal E. Hourany A.S. Ignatov R. Kunnel A. Lapik A. Lleres P. Levi Sandri F. Mammoliti G. Mandaglio M. Manganaro M. Moricciani A.N. Mushkarenkov V.G. Nedorezov C. Randieri D. Rebreyend N.V. Rudnev G. Russo C. Schaerf M.L. Sperduto M.C. Sutera A.Turinge | 2009 | Chinese Physics C2009，33，12： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员